TMS for treatment-resistant depression in adults
Part of Mental health clinical trials.
This study tests a new type of transcranial magnetic stimulation (TMS) for adults whose depression hasn't gotten better with medication. It compares the real treatment to a sham (inactive) version to see how well it works.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 22 and 85 years old.
- You have major depression (without psychosis) that hasn't improved enough with antidepressant medication.
- Your depression score on a standard scale is above 20.
- You haven't changed your depression medication or therapy in the last 4 weeks, and you agree not to change it during the study.
- You do not have epilepsy, seizures, or any condition that prevents MRI or TMS.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether using brain-related “biomarkers” from your scans to guide rTMS can improve depression that hasn’t responded to at least one antidepressant. It may help by targeting brain circuits linked to depression more precisely.
This study tests an in-hospital brain stimulation treatment (TMS) for people with moderate to severe depression who did not improve after multiple antidepressant treatments. It may help your mood by targeting brain circuits involved in depression, and you would follow an intensive accelerated schedule.
This trial tests an alternating combination of brain stimulation and brain imaging to see if it helps people with depression that hasn’t improved with usual treatments. The goal is to find a safer, more effective approach for people whose depression has been very difficult to treat.
This study tests whether ongoing rTMS treatments can help people who already improved after an initial round of rTMS for depression. It aims to keep the benefits going and prevent relapse.
This study tests a new type of magnetic brain stimulation (called TMS) for depression. It uses a sham (fake) treatment as a comparison to see if the rapid-acting version is effective and safe.
This study tests a new way of delivering brain stimulation called rTMS to treat depression that hasn't improved with standard treatments. The goal is to see if targeting specific brain areas helps reduce depression symptoms more effectively.
Hear when a new Major Depressive Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.